2016 ACS CAN Connecticut Forum: Personalized Medicine

The American Cancer Society Cancer Action Network (ACS CAN), the advocacy affiliate of the American Cancer Society, is the nation’s leading cancer advocacy organization working every day to make cancer issues a top priority.  ACS CAN unites and empowers cancer patients, survivors, caregivers, and their loved ones, giving them the training and tools they need to be heard.  ACS CAN’s public policy priorities are focused on the actions that elected leaders at all levels of government can take to accelerate the ability to save lives and win the fight against cancer.

ACS CAN is launching an annual Connecticut public policy forum on December 1, 2016 at the Conference Center at Yale West in Orange, CT.  The goal is to create a dialogue for leaders in business, health care, academia, public policy, patient advocacy, as well as other stakeholders to capture the latest and best thinking about the potential impact of personalized medicine on patients – particularly people living with cancer.

Focus of the forum

This event will focus on advances in therapies and diagnostics that are revolutionizing cancer care and will include leaders from the oncology community, including life sciences, health care systems, academia, patient advocacy, and provider groups.  ACS CAN will use this event to help illustrate and answer the following questions:

• What are patient expectations for personalized medicine?
• How can cancer patients benefit from genetic testing and targeted therapies?
• How do we ensure personalized medicine is practiced in a reliable way that optimizes patient outcomes?
• What is needed to integrate personalized medicine into clinical practice, including in community settings?
• What are the barriers to patients accessing personalized medicine?
• What is needed to continue to promote new advances in personalized medicine?

Confirmed Speakers

• Andrew Baskin, MD - National Medical Director for Quality and Provider Performance Measurement, Aetna
• Meg Eckenroad - Vice President, Women's Health & Professional Relations, Hologic
• Roy S. Herbst, MD, PhD - Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; Associate Director for Translational Research, Yale Cancer Center  
• Jocelyn Maminta - Medical Reporter, WTNH News 8 New Haven
• Cecilia Schott - Vice President, Precision Medicine, AstraZeneca

Sponsorship

Sponsorship opportunities are available for this event.  Please contact Bryte Johnson, Director of Government Relations at [email protected] for more information about ACS CAN, this event, or sponsorship opportunities.

Thank you to our sponsors